Yanjun Wang

Changchun, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Association between islet β-cell function and time in range in patients with type 2 diabetes mellitus: a retrospective cross-sectional study.

Association between islet β-cell function and time in range in patients with type 2 diabetes mellitus: a retrospective cross-sectional study.

Journal: Frontiers in endocrinology
Published: June 06, 2026

Body composition-derived principal components partially explain sex and age effects on bone mineral density in type 2 diabetes mellitus.

Body composition-derived principal components partially explain sex and age effects on bone mineral density in type 2 diabetes mellitus.

Journal: Frontiers in endocrinology
Published: February 15, 2026

Ginsenoside in the treatment of type 2 diabetes and its complications: a promising traditional chinese medicine.

Ginsenoside in the treatment of type 2 diabetes and its complications: a promising traditional chinese medicine.

Journal: Frontiers in pharmacology
Published: March 18, 2025

Rapid Onset of Pain Relief with Crisugabalin in Patients with Diabetic Peripheral Neuropathic Pain: Findings from a Multicenter, Randomized, Double-Blind, Controlled Study.

Rapid Onset of Pain Relief with Crisugabalin in Patients with Diabetic Peripheral Neuropathic Pain: Findings from a Multicenter, Randomized, Double-Blind, Controlled Study.

Journal: Pain and therapy
Published: February 27, 2025

GABA Analogue HSK16149 in Chinese Patients With Diabetic Peripheral Neuropathic Pain: A Phase 3 Randomized Clinical Trial.

GABA Analogue HSK16149 in Chinese Patients With Diabetic Peripheral Neuropathic Pain: A Phase 3 Randomized Clinical Trial.

Journal: JAMA network open
Published: August 19, 2024

Predictive value of IGF-1/IGFBP-3 ratio for thyroid nodules in type 2 diabetic mellitus.

Predictive value of IGF-1/IGFBP-3 ratio for thyroid nodules in type 2 diabetic mellitus.

Journal: Frontiers in endocrinology
Published: June 05, 2024

Taxifolin Inhibits the Growth of Non-Small-Cell Lung Cancer via Downregulating Genes Displaying Novel and Robust Associations with Immune Evasion Factors.

Taxifolin Inhibits the Growth of Non-Small-Cell Lung Cancer via Downregulating Genes Displaying Novel and Robust Associations with Immune Evasion Factors.

Journal: Cancers
Published: August 24, 2023

Taxifolin Inhibits Breast Cancer Growth by Facilitating CD8+ T Cell Infiltration and Inducing a Novel Set of Genes including Potential Tumor Suppressor Genes in 1q21.3.

Taxifolin Inhibits Breast Cancer Growth by Facilitating CD8+ T Cell Infiltration and Inducing a Novel Set of Genes including Potential Tumor Suppressor Genes in 1q21.3.

Journal: Cancers
Published: April 24, 2023

Fotagliptin monotherapy with alogliptin as an active comparator in patients with uncontrolled type 2 diabetes mellitus: a randomized, multicenter, double-blind, placebo-controlled, phase 3 trial.

Fotagliptin monotherapy with alogliptin as an active comparator in patients with uncontrolled type 2 diabetes mellitus: a randomized, multicenter, double-blind, placebo-controlled, phase 3 trial.

Journal: BMC medicine
Published: April 06, 2023

Comparison of Plasma Exosome Proteomes Between Obese and Non-Obese Patients with Type 2 Diabetes Mellitus.

Comparison of Plasma Exosome Proteomes Between Obese and Non-Obese Patients with Type 2 Diabetes Mellitus.

Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: November 11, 2022

Deep Learning-Based Image Automatic Assessment and Nursing of Upper Limb Motor Function in Stroke Patients.

Deep Learning-Based Image Automatic Assessment and Nursing of Upper Limb Motor Function in Stroke Patients.

Journal: Journal of healthcare engineering
Published: June 24, 2021

Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study.

Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study.

Journal: Diabetologia
Published: May 26, 2021
Showing 1-12 of 26

Last Updated: 09/26/2026